Literature DB >> 25480728

Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis.

Fábio Guilherme Campos1, Carlos Augusto Real Martinez, Marleny Novaes, Sérgio Carlos Nahas, Ivan Cecconello.   

Abstract

Background/Aims Desmoid tumors (DTs) are rare, locally invasive neoplasms that may affect 10-25% of familial adenomatous polyposis (FAP) patients. Our aim was to evaluate incidence and clinical presentation among our patients, the potential impact on FAP outcome and to discuss treatment. Materials and methods Charts from 133 FAP (1977-2013) were reviewed. Patients with DTs were separated to retrieve demographic, clinical and management data. Follow-up was focused on disease evolution causing complications or death. Results 19 (14.3%) DTs were diagnosed, either after previous trauma (16) or during FAP surgery (3). This group comprised 8 men (42.1%) and 11 women (57.9%) with an average age of 32.9 years. Intervals from surgical trauma to DTs ranged from 7 to 60 months. ECMs were detected in 12 (63.1%) patients. DTs were located in the abdominal wall (8), abdominal cavity (8), abdominal wall and cavity (2) and left arm (1). Five patients (26.3%) referred family history of DTs. Patients presented severe complications such as small bowel obstruction (4) and hydronephrosis (2), being directly responsible for death in three patients. Conclusions (1) DTs developed in 14.3% of FAP, mostly after surgical trauma; (2) 30% caused severe morbidity; (3) identification of clinical risk factors may help surgeons to develop screening and therapeutic decisions.

Entities:  

Mesh:

Year:  2015        PMID: 25480728     DOI: 10.1007/s10689-014-9772-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  44 in total

1.  Stepwise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system.

Authors:  Simon B Middleton; Susan K Clark; Paul Matravers; David Katz; Rodney Reznek; Robin K S Phillips
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

2.  [Desmoid tumour as indication of familial adenomatous polyposis].

Authors:  Marry H Nieuwenhuis; Henk H Hartgrink; Sybren Meijer; Fred H Menko; Hans F A Vasen
Journal:  Ned Tijdschr Geneeskd       Date:  2010

3.  Surgical outcomes of laparoscopic colorectal resections for familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Sérgio Eduardo Araújo; Armando Geraldo Melani; Luís Cláudio Pandini; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-10       Impact factor: 1.719

4.  Causes of death in familial adenomatous polyposis.

Authors:  T S Galle; K Juel; S Bülow
Journal:  Scand J Gastroenterol       Date:  1999-08       Impact factor: 2.423

5.  A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.

Authors:  Marry H Nieuwenhuis; Mariel Casparie; Lisbeth M H Mathus-Vliegen; Olaf M Dekkers; Pancras C W Hogendoorn; Hans F A Vasen
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

6.  Risk factors for development of desmoid tumours in familial adenomatous polyposis.

Authors:  J H Lefevre; Y Parc; S Kernéis; N Goasguen; M Benis; R Parc; E Tiret
Journal:  Br J Surg       Date:  2008-09       Impact factor: 6.939

7.  Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.

Authors:  D Speake; D G Evans; F Lalloo; N A Scott; J Hill
Journal:  Br J Surg       Date:  2007-08       Impact factor: 6.939

8.  Extra-abdominal desmoid tumors associated with familial adenomatous polyposis.

Authors:  George T Calvert; Michael J Monument; Randall W Burt; Kevin B Jones; R Lor Randall
Journal:  Sarcoma       Date:  2012-06-03

Review 9.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

10.  Aggressive fibromatosis: evidence for a stable phase.

Authors:  G Mitchell; J M Thomas; C L Harmer
Journal:  Sarcoma       Date:  1998
View more
  10 in total

Review 1.  Adenomatous Polyposis Syndromes: Diagnosis and Management.

Authors:  Jonathan B Mitchem; Jason F Hall
Journal:  Clin Colon Rectal Surg       Date:  2016-12

Review 2.  Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.

Authors:  Priyanka Kanth; Jade Grimmett; Marjan Champine; Randall Burt; N Jewel Samadder
Journal:  Am J Gastroenterol       Date:  2017-08-08       Impact factor: 10.864

3.  Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.

Authors:  Winan J van Houdt; Iris H Wei; Deborah Kuk; Li-Xuan Qin; Bhumika Jadeja; Anthony Villano; Meera Hameed; Samuel Singer; Aimee M Crago
Journal:  Ann Surg Oncol       Date:  2019-01-04       Impact factor: 5.344

4.  Gastrointestinal Complications of Intra-Abdominal Desmoid Tumors: A Case Report and Review of the Literature.

Authors:  Darcy Morris; Raquel Gonzalez; Jane Cook; Jonathan Metts; Peter Shaw
Journal:  Case Rep Oncol       Date:  2022-05-12

5.  Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs.

Authors:  Mohamed M Gad; Anne-Marie Langevin; Aaron J Sugalski; Gail E Tomlinson
Journal:  Fam Cancer       Date:  2020-10       Impact factor: 2.375

Review 6.  Duodenal adenoma surveillance in patients with familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Marianny Sulbaran; Adriana Vaz Safatle-Ribeiro; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

Review 7.  Desmoid Tumors Characteristics, Clinical Management, Active Surveillance, and Description of Our FAP Case Series.

Authors:  Lupe Sanchez-Mete; Virginia Ferraresi; Mauro Caterino; Aline Martayan; Irene Terrenato; Elena Mannisi; Vittoria Stigliano
Journal:  J Clin Med       Date:  2020-12-11       Impact factor: 4.241

8.  Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors.

Authors:  Haotian Liu; Kai Huang; Tao Li; Tielong Yang; Zhichao Liao; Chao Zhang; Lijie Xiang; Yong Chen; Jilong Yang
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

9.  Proof of principle for bevacizumab activity in desmoid-type fibromatosis.

Authors:  Viktor Grünwald; Florian Länger; H J Raatschen; Andreas Beilken
Journal:  Clin Sarcoma Res       Date:  2016-04-04

10.  Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis.

Authors:  Elena Palassini; Bruno Vincenzi; Andrea Napolitano; Salvatore Provenzano; Chiara Colombo; Marco Vitellaro; Antonella Brunello; Giuseppe Badalamenti; Margherita Nannini; Toni Ibrahim; Peter Hohenberger; Silvia Gasperoni; Spyridon Gennatas; Robin L Jones; Nadia Hindi; Javier Martin-Broto; Mariella Spalato Ceruso; Marianna Silletta; Angelo Paolo Dei Tos; Alessandro Gronchi; Silvia Stacchiotti; Daniele Santini; Giuseppe Tonini
Journal:  ESMO Open       Date:  2020-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.